← SynDRA
NACUBACTAM
SynDRA canonical compound SYN0039179 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | LACTB |
| Mechanism of action | beta lactamase inhibitor |
All known targets
Mechanisms of action (all sources)
- beta lactamase inhibitor
- Inhibitor
Cross-references
Synonyms
- FPI-1459
- RG-6080
- RG6080
- RO-7079901
- RO7079901
- OP-0595
- UNII-832O37V7MZ
- 832O37V7MZ
- 1452458-86-4 (free acid)
- (1R,2S,5R)-2-((2-aminoethoxy)carbamoyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate
- Nacubactam [INN]
- Nacubactam (USAN)
- Nacubactam [USAN:INN]
- CHEMBL3989959
- SCHEMBL15206610
- SCHEMBL17975933
- GTPL10833
- MFCD28986228
- OP0595
- ZINC207610051
- DB15353
- SB17180
- AS-35134
- HY-109008
- CS-0030506
- D11329
- Q27269383
- (1R,2S,5R)-2-((2-Aminoethoxy)carbamoyl)-7-oxo- 1,6-diazabicyclo(3.2.1)octan-6-yl hydrogen sulfate
- (2S,5R)-2-(2-Aminoethoxycarbamoyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate
- (2S,5R)-N-(2-Aminoethoxy)-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide
- [(2S,5R)-2-(2-aminoethoxycarbamoyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate
- Sulfuric acid, mono((1R,2S,5R)-2-(((2-aminoethoxy)amino)carbonyl)-7-oxo-1,6-diazabicyclo(3.2.1)oct-6-yl) ester
- Sulfuric acid, mono((1R,2S,5R)-2-(((2-aminoethoxy)amino)carbonyl)-7-oxo-1,6-diazabicyclo(3.2.1)oct-6-yl) ester, (-)-
- nacubactamum
- RefChem:164386
- Nacubactam (JAN/USAN)
- NACUBACTAM [USAN]
- NACUBACTAM [WHO-DD]
- C9H16N4O7S
Look up NACUBACTAM in the interactive SynDRA portal →